RU2016144359A - Способ диагностики туберкулезного менингита - Google Patents

Способ диагностики туберкулезного менингита Download PDF

Info

Publication number
RU2016144359A
RU2016144359A RU2016144359A RU2016144359A RU2016144359A RU 2016144359 A RU2016144359 A RU 2016144359A RU 2016144359 A RU2016144359 A RU 2016144359A RU 2016144359 A RU2016144359 A RU 2016144359A RU 2016144359 A RU2016144359 A RU 2016144359A
Authority
RU
Russia
Prior art keywords
sample
tbm
biomarkers
capture agents
proteins
Prior art date
Application number
RU2016144359A
Other languages
English (en)
Russian (ru)
Other versions
RU2016144359A3 (zh
Inventor
Новел Нджвейпи ЧЕГОУ
Герхард ВАЛЗЛ
Анне Марселине ВАН ФЮРТ
Дауве Хендрик ВИССЕР
Original Assignee
Стелленбос Юниверсити
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Стелленбос Юниверсити filed Critical Стелленбос Юниверсити
Publication of RU2016144359A publication Critical patent/RU2016144359A/ru
Publication of RU2016144359A3 publication Critical patent/RU2016144359A3/ru

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4721Cationic antimicrobial peptides, e.g. defensins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • G01N2333/5437IL-13

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
RU2016144359A 2014-04-15 2015-04-15 Способ диагностики туберкулезного менингита RU2016144359A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA2014/02743 2014-04-15
ZA201402743 2014-04-15
PCT/IB2015/052751 WO2015159239A1 (en) 2014-04-15 2015-04-15 A method for diagnosing tuberculous meningitis

Publications (2)

Publication Number Publication Date
RU2016144359A true RU2016144359A (ru) 2018-05-15
RU2016144359A3 RU2016144359A3 (zh) 2018-05-15

Family

ID=54323552

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016144359A RU2016144359A (ru) 2014-04-15 2015-04-15 Способ диагностики туберкулезного менингита

Country Status (5)

Country Link
EP (1) EP3132270A4 (zh)
CN (1) CN106461674A (zh)
AP (1) AP2016009538A0 (zh)
RU (1) RU2016144359A (zh)
WO (1) WO2015159239A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017178826A1 (en) * 2016-04-14 2017-10-19 The University Of Liverpool Diagnosing acute bacterial meningitis
CN107421875A (zh) * 2017-04-29 2017-12-01 济南市儿童医院 Mfsd2a在制备诊断化脓性脑膜炎制品中的应用
US20210199668A1 (en) * 2018-05-23 2021-07-01 Stellenbosch University Biomarkers for diagnosing tuberculous meningitis
CN112899340B (zh) * 2021-03-15 2022-09-27 首都医科大学附属北京胸科医院 一种辅助诊断结核性脑膜炎的试剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1405076B1 (en) * 2001-05-18 2010-08-25 Virogates APS A method of diagnosing or prognosticating major respiratory bacterial pathogens in a subject
AU2005266921B2 (en) * 2004-07-23 2009-07-23 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
US20110129817A1 (en) * 2009-11-30 2011-06-02 Baylor Research Institute Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection
AU2009262112A1 (en) * 2008-06-25 2009-12-30 Baylor Research Institute Blood transcriptional signature of mycobacterium tuberculosis infection
WO2013175459A2 (en) * 2012-05-25 2013-11-28 Stellenbosch University Method for diagnosing tuberculosis disease

Also Published As

Publication number Publication date
EP3132270A4 (en) 2017-09-13
WO2015159239A4 (en) 2015-12-17
CN106461674A (zh) 2017-02-22
WO2015159239A1 (en) 2015-10-22
AP2016009538A0 (en) 2016-11-30
RU2016144359A3 (zh) 2018-05-15
EP3132270A1 (en) 2017-02-22

Similar Documents

Publication Publication Date Title
JP2019530875A5 (zh)
Penny et al. Accuracy of a no-biopsy approach for the diagnosis of coeliac disease across different adult cohorts
RU2016137685A (ru) Способ диагностики туберкулеза
RU2016144359A (ru) Способ диагностики туберкулезного менингита
JP2015519564A5 (zh)
EP2791679A1 (en) Methods and kits for diagnosing latent tuberculosis infection
RU2013118307A (ru) Новый способ диагностики белезни лайма с использованием теста клеточного иммунного ответа
JP2017531801A5 (zh)
JP2017502253A5 (zh)
CY1119797T1 (el) Λακτοφερινη για χρηση στη διαγνωση και προγνωση της νοσου alzheimer
RU2016116766A (ru) Диагностика и лечение синдрома раздраженного кишечника и воспалительного заболевания кишечника
Oh et al. Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-β in plasma
JP2017524933A5 (zh)
WO2003081236B1 (en) Method and device for predicting cardiovascular events
Bayart et al. Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
EP3443356B1 (en) Host biomarkers for immunodiagnosis and monitoring of tuberculosis disease
Kumar et al. Development of the Com1 synthetic peptide-based Latex Agglutination Test (LAT) and its comparative evaluation with commercial indirect-ELISA for sero-screening of coxiellosis in cattle
JP7109441B2 (ja) 神経変性疾患を判定するための診断補助方法
RU2020127365A (ru) Способы, применения и комплекты для диагностики пародонтита
Zhang et al. Quantitative and rapid detection of microcystin-LR using time-resolved fluorescence immunochromatographic assay based on europium nanospheres
JP2021510815A5 (zh)
Nguyen et al. Capillary electrophoresis-laser-induced fluorescence (CE-LIF)-based immunoassay for quantifying antibodies against cyclic citrullinated peptides
Zhang et al. Platelet proteomics in diagnostic differentiation of primary immune thrombocytopenia using SELDI-TOF-MS
RU2017107273A (ru) Антилимфоцитарные аутоантитела в качестве диагностических биомаркеров
JP2019525175A5 (zh)